For EFSA, risk analysis of GMOs must become the exception
New GMOs: a deleterious link between regulation and patents
GMOs: will the CJEU uphold its 2018 ruling?
GMOs: the corporate communication department to the rescue
Objective 2030: deregulate most GMOs in Europe?
Public consultations ahead of deregulation of new GMOs?
Traceability of new GMOs: the European Commission’s blinkers
GMO – Cell culture techniques are not traditional
EPO : new GMOs can be differentiated
According to companies, GMO products of genetic modification techniques are patentable because they are considered “inventions”. But to obtain these patents, the European Patent Office (EPO) require from the applicants to be clear about the techniques used for obtaining the organisms or genetic sequences covered by their patent. This obligation shows that, for the EPO, it is possible to differentiate, e.g. between GMOs obtained by patentable mutagenesis techniques on the one hand, and GMOs obtained by other techniques or any other organisms present in nature, on the other hand.
Are new GMOs listed in the plant variety databases ?
No labelling for additives produced from GMO micro-organisms
Journal